42 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
or as a result of such director, officer, employee or consultant’s termination, death or disability.
“Disqualified Person” has the meaning set forth … , disability or other employee benefits or property, casualty or liability insurance to the Company or any Subsidiary incurred in connection
8-K
ui195ks
26 Jun 20
Departure of Directors or Certain Officers
4:00pm
DEF 14A
uhnbesk zrs99vwnhvp0
24 Apr 20
Definitive proxy
4:15pm
424B4
i77dk4ccf8
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
v84qap
9 Jan 20
Draft registration statement
12:00am
10-Q
EX-10.12
xse2 2qjy451
13 Aug 19
Quarterly report
4:36pm
8-K
EX-10.2
8h1tritmx43eup4otj
7 Aug 19
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
5:29pm
S-8
EX-99.1
dgcs1gb4gb05tj
1 Jul 19
Registration of securities for employees
5:22pm
8-K
EX-3.2
3iovfnk3l2yl2jom
1 Jul 19
Adaptive Biotechnologies Announces Pricing of Initial Public Offering
4:41pm
424B4
lsn63uim1vo6
27 Jun 19
Prospectus supplement with pricing info
5:24pm